J&J blood clot risk is less than 1 in a million. Don’t be skeptical about the vaccine, docs say.

April 14, 2021 • Rebecca Everett • Nj.com
a box of the Johnson & Johnson COVID-19 vaccine is shown in a refrigerator

“I think the main point is that this is a rare problem,” said Dr. Martin Blaser, director of Rutgers Center for Advanced Biotechnology and Medicine and an investigator on the university’s Johnson & Johnson vaccine trial.

“We have many drugs with risks of serious complications much greater than this one,” said Blaser, also a professor of medicine. “Non steroidal anti-inflammatory medication, people can get fatal problems with that, but they’re very rare. And that’s why we’re able to use them.”